Sanofi (SNYNF) Net Margin (2009 - 2026)

Sanofi (SNYNF) posted Net Margin of 56.37% for Q2 2026, down 467.02% sequentially from 15.36% in Q1 2026, and down 9579.0% YoY from 0.59% in Q2 2025.

Sanofi (SNYNF) Net Margin (2009 - 2026) Analysis & Trends

Sanofi has reported Net Margin for 18 years, with the latest figure at 56.37% in Q2 2026.

Quarterly Net Margin fell 9579.0% year-over-year to 56.37% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 6.23% (down 3019.0% YoY) and the FY2025 annual result came in at 17.91%, up 437.0% from the prior year.
Net Margin fell to 56.37% in Q2 2026 per SNYNF's latest filing, from 15.36% in the prior quarter.
Over five years, Net Margin peaked at 77.02% in Q4 2025 and troughed at 56.37% in Q2 2026.
A 5-year average of 16.4% and a median of 16.47% in 2022 frame the typical range for Net Margin.
The sharpest annual moves came in 2025 and 2026: Net Margin jumped 6927 bps in 2025, then sank 9579 bps in 2026.
Over 5 years, Net Margin stood at 16.3% in 2022, then tumbled by 109 bps to 1.47% in 2023, then surged by 628 bps to 7.76% in 2024, then soared by 893 bps to 77.02% in 2025, then tumbled by 173 bps to 56.37% in 2026.
According to Business Quant data, Net Margin over the past three periods registered 56.37%, 15.36%, and 77.02% for Q2 2026, Q1 2026, and Q4 2025 respectively.

Download Data